Hepatitis Monthly

Published by: Kowsar

In Silico Identification and Conservation Analysis of B-cell and T-Cell Epitopes of Hepatitis C Virus 3a Genotype Enveloped Glycoprotein 2 From Pakistan: A Step Towards Heterologous Vaccine Design

Aqsa Ikram 1 , Sadia Anjum 1 , * and Muhammad Tahir 1
Authors Information
1 Atta-Ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan
Article information
  • Hepatitis Monthly: June 01, 2014, 14 (6); e9832
  • Published Online: June 1, 2014
  • Article Type: Research Article
  • Received: February 28, 2013
  • Revised: July 22, 2013
  • Accepted: October 17, 2013
  • DOI: 10.5812/hepatmon.9832

To Cite: Ikram A, Anjum S, Tahir M. In Silico Identification and Conservation Analysis of B-cell and T-Cell Epitopes of Hepatitis C Virus 3a Genotype Enveloped Glycoprotein 2 From Pakistan: A Step Towards Heterologous Vaccine Design, Hepat Mon. 2014 ;14(6):e9832. doi: 10.5812/hepatmon.9832.

Abstract
Copyright © 2014, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005; 5(9): 558-67[DOI][PubMed]
  • 2. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol. 2007; 13(17): 2436-41[PubMed]
  • 3. Grebely J, Matthews GV, Dore GJ. Treatment of acute HCV infection. Nat Rev Gastroenterol Hepatol. 2011; 8(5): 265-74[DOI][PubMed]
  • 4. Alberti A, Vario A, Ferrari A, Pistis R. Review article: chronic hepatitis C--natural history and cofactors. Aliment Pharmacol Ther. 2005; 22 Suppl 2: 74-8[DOI][PubMed]
  • 5. Dash S, Haque S, Joshi V, Prabhu R, Hazari S, Fermin C, et al. HCV-hepatocellular carcinoma: new findings and hope for effective treatment. Microsc Res Tech. 2005; 68(3-4): 130-48[DOI][PubMed]
  • 6. Asselah T, Rubbia-Brandt L, Marcellin P, Negro F. Steatosis in chronic hepatitis C: why does it really matter? Gut. 2006; 55(1): 123-30[DOI][PubMed]
  • 7. Alavian SM, Aalaei-Andabili SH. More risk factors of hepatitis C transmission should be considered in Pakistan. Int J Prev Med. 2011; 2(3): 188-9[PubMed]
  • 8. Idrees M, Riazuddin S. Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infect Dis. 2008; 8: 69[DOI][PubMed]
  • 9. Idrees M, Rafique S, Rehman I, Akbar H, Yousaf MZ, Butt S, et al. Hepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experience. World J Gastroenterol. 2009; 15(40): 5080-5[PubMed]
  • 10. Kato N. Genome of human hepatitis C virus (HCV): gene organization, sequence diversity, and variation. Microb Comp Genomics. 2000; 5(3): 129-51[PubMed]
  • 11. Irshad M, Ansari MA, Singh A, Nag P, Raghvendra L, Singh S, et al. HCV-genotypes: a review on their origin, global status, assay system, pathogenecity and response to treatment. Hepatogastroenterology. 2010; 57(104): 1529-38[PubMed]
  • 12. Lang Kuhs KA, Ginsberg AA, Yan J, Wiseman RW, Khan AS, Sardesai NY, et al. Hepatitis C virus NS3/NS4A DNA vaccine induces multiepitope T cell responses in rhesus macaques mimicking human immune responses [corrected]. Mol Ther. 2012; 20(3): 669-78[DOI][PubMed]
  • 13. Mancini N, Diotti RA, Perotti M, Sautto G, Clementi N, Nitti G, et al. Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes. PLoS One. 2009; 4(12)[DOI][PubMed]
  • 14. Lee JW, Kim K, Jung SH, Lee KJ, Choi EC, Sung YC, et al. Identification of a domain containing B-cell epitopes in hepatitis C virus E2 glycoprotein by using mouse monoclonal antibodies. J Virol. 1999; 73(1): 11-8[PubMed]
  • 15. Keck ZY, Xia J, Wang Y, Wang W, Krey T, Prentoe J, et al. Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate. PLoS Pathog. 2012; 8(4)[DOI][PubMed]
  • 16. Allander T, Drakenberg K, Beyene A, Rosa D, Abrignani S, Houghton M, et al. Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81. J Gen Virol. 2000; 81: 2451-9[PubMed]
  • 17. Edwards VC, Tarr AW, Urbanowicz RA, Ball JK. The role of neutralizing antibodies in hepatitis C virus infection. J Gen Virol. 2012; 93: 1-19[DOI][PubMed]
  • 18. Giang E, Dorner M, Prentoe JC, Dreux M, Evans MJ, Bukh J, et al. Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus. Proc Natl Acad Sci U S A. 2012; 109(16): 6205-10[DOI][PubMed]
  • 19. Memarnejadian A, Roohvand F, Arashkia A, Rafati S, Shokrgozar MA. Polytope DNA vaccine development against hepatitis C virus: a streamlined approach from in silico design to in vitro and primary in vivo analyses in BALB/c mice. Protein Pept Lett. 2009; 16(7): 842-50[PubMed]
  • 20. Roohvand F, Kossari N. Advances in hepatitis C virus vaccines, part two: advances in hepatitis C virus vaccine formulations and modalities. Expert Opin Ther Pat. 2012; 22(4): 391-415[DOI][PubMed]
  • 21. Arashkia A, Roohvand F, Memarnejadian A, Aghasadeghi MR, Rafati S. Construction of HCV-polytope vaccine candidates harbouring immune-enhancer sequences and primary evaluation of their immunogenicity in BALB/c mice. Virus Genes. 2010; 40(1): 44-52[DOI][PubMed]
  • 22. Bui HH, Sidney J, Li W, Fusseder N, Sette A. Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines. BMC Bioinformatics. 2007; 8: 361[DOI][PubMed]
  • 23. Singh H, Raghava GP. ProPred1: prediction of promiscuous MHC Class-I binding sites. Bioinformatics. 2003; 19(8): 1009-14[PubMed]
  • 24. Sturniolo T, Bono E, Ding J, Raddrizzani L, Tuereci O, Sahin U, et al. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat Biotechnol. 1999; 17(6): 555-61[DOI][PubMed]
  • 25. Sominskaya I, Alekseeva E, Skrastina D, Mokhonov V, Starodubova E, Jansons J, et al. Signal sequences modulate the immunogenic performance of human hepatitis C virus E2 gene. Mol Immunol. 2006; 43(12): 1941-52[DOI][PubMed]
  • 26. Florea L, Halldorsson B, Kohlbacher O, Schwartz R, Hoffman S, Istrail S. Epitope prediction algorithms for peptide-based vaccine design. Proc IEEE Comput Soc Bioinform Conf. 2003; 2: 17-26[PubMed]
  • 27. Morin TJ, Broering TJ, Leav BA, Blair BM, Rowley KJ, Boucher EN, et al. Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees. PLoS Pathog. 2012; 8(8)[DOI][PubMed]
  • 28. Idrees S, Ashfaq UA, Khaliq S. HCV Envelope protein 2 sequence comparison of Pakistani isolate and In-silico prediction of conserved epitopes for vaccine development. J Transl Med. 2013; 11: 105[DOI][PubMed]
  • 29. Kachko A, Kochneva G, Sivolobova G, Grazhdantseva A, Lupan T, Zubkova I, et al. New neutralizing antibody epitopes in hepatitis C virus envelope glycoproteins are revealed by dissecting peptide recognition profiles. Vaccine. 2011; 30(1): 69-77[DOI][PubMed]
  • 30. Pan M, Wang X, Liao J, Yin D, Li S, Pan Y, et al. Prediction and identification of potential immunodominant epitopes in glycoproteins B, C, E, G, and I of herpes simplex virus type 2. Clin Dev Immunol. 2012; 2012: 205313[DOI][PubMed]
  • 31. Hou Y, Guo Y, Wu C, Shen N, Jiang Y, Wang J. Prediction and identification of T cell epitopes in the H5N1 influenza virus nucleoprotein in chicken. PLoS One. 2012; 7(6)[DOI][PubMed]
  • 32. El-Awady MK, Tabll AA, El-Abd YS, Yousif H, Hegab M, Reda M, et al. Conserved peptides within the E2 region of Hepatitis C virus induce humoral and cellular responses in goats. Virol J. 2009; 6: 66[DOI][PubMed]
  • 33. Youn JW, Park SH, Cho JH, Sung YC. Optimal induction of T-cell responses against hepatitis C virus E2 by antigen engineering in DNA immunization. J Virol. 2003; 77(21): 11596-602[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments